RCS Capital Corp (RCAP) Drops 25% on January 15

Equities Staff |

RCS Capital Corp (RCAP) was one of the Russell 2000's biggest losers for Friday January 15 as the stock slid 25% to $0.01, a loss of $-0.003 per share. Starting at an opening price of $0.01 a share, the stock traded between $0.01 and $0.01 over the course of the trading day. Volume was 905,739 shares over 56 trades, against an average daily volume of 1.38 million shares and a total float of 91.95 million.

The losses send RCS Capital Corp down to a market cap of $827,522. In the last year, RCS Capital Corp has traded between $12.34 and $0.01, and its 50-day SMA is currently $0.35 and 200-day SMA is $3.83.

RCS Capital Corp is a holding company. The Company, through its subsidiaries, is engaged in the wholesale distribution and investment banking, capital markets and transaction management services businesses.

RCS Capital Corp is based out of New York, NY and has some 2,128 employees. Its CEO is R. Lawrence Roth.

For a complete fundamental analysis analysis of RCS Capital Corp, check out Equities.com’s Stock Valuation Analysis report for RCAP. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

GSV Capital Corp

GSV Capital Corp is an externally managed, non-diversified closed-end management investment company. The Company has elected to be treated as a business development company.

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…

WayBetter

The spark hit Jamie when he saw co-workers competing to lose weight. Instead of pizzas and subs, they were eating salads and jogging along the river. Some were sneakily leaving…